{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:18:13Z","timestamp":1793409493356,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20200316"],"award-info":[{"award-number":["BK20200316"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["14380470"],"award-info":[{"award-number":["14380470"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018594","name":"Central University Basic Research Fund of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2308200"],"award-info":[{"award-number":["2023YFC2308200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81071859"],"award-info":[{"award-number":["81071859"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bbadis.2024.167122","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T05:21:23Z","timestamp":1710566483000},"page":"167122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["An engineered TNFR1-selective human lymphotoxin-alpha mutant delivered by an oncolytic adenovirus for tumor immunotherapy"],"prefix":"10.1016","volume":"1870","author":[{"given":"Yan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongge","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3065-1336","authenticated-orcid":false,"given":"Erguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2024.167122_bb0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/intimm\/dxt018","article-title":"Linking the microbiota and metabolic disease with lymphotoxin","volume":"25","author":"Upadhyay","year":"2013","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0010","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/2191076a0","article-title":"Lymphocyte in vitro cytotoxicity: lymphotoxins of several mammalian species","volume":"219","author":"Williams","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2024.167122_bb0015","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1073\/pnas.83.6.1881","article-title":"DNA fragmentation: manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant","volume":"83","author":"Schmid","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2024.167122_bb0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00262-007-0352-x","article-title":"Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue","volume":"57","author":"Schrama","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbadis.2024.167122_bb0025","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.4049\/jimmunol.163.5.2809","article-title":"Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment","volume":"163","author":"Ito","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0030","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4049\/jimmunol.163.3.1350","article-title":"Multiple deficiencies underlie NK cell inactivity in lymphotoxin-alpha gene-targeted mice","volume":"163","author":"Smyth","year":"1999","journal-title":"J. Immunol."},{"issue":"Pt 3","key":"10.1016\/j.bbadis.2024.167122_bb0035","first-page":"27","article-title":"Recombinant antibody fusion proteins for cancer immunotherapy","volume":"213","author":"Reisfeld","year":"1996","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1074-7613(01)00094-2","article-title":"Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue","volume":"14","author":"Schrama","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2024.167122_bb0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4161\/cbt.7.9.6429","article-title":"Platinums sensitize human epithelial tumor cells to lymphotoxin alpha by inhibiting NFkappaB-dependent transcription","volume":"7","author":"Shen","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbadis.2024.167122_bb0050","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/s41418-021-00834-8","article-title":"Lymphotoxin: from the physiology to the regeneration of the thymic function","volume":"28","author":"Borelli","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2024.167122_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0163-7258(93)90037-E","article-title":"Tumor-necrosis-factor activities and Cancer-therapy - a perspective","volume":"57","author":"Sidhu","year":"1993","journal-title":"Pharmacol Therapeut"},{"key":"10.1016\/j.bbadis.2024.167122_bb0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000227329","article-title":"Tumor necrosis factor for the treatment of malignancies","volume":"51","author":"Hieber","year":"1994","journal-title":"Oncology"},{"key":"10.1016\/j.bbadis.2024.167122_bb0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2024.167122_bb0070","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1182\/blood.V85.10.2779.bloodjournal85102779","article-title":"Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice","volume":"85","author":"Qin","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2024.167122_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2014.02.001","article-title":"Lymphotoxin and TNF: how it all began-a tribute to the travelers","volume":"25","author":"Ruddle","year":"2014","journal-title":"Cytokine Growth F R"},{"key":"10.1016\/j.bbadis.2024.167122_bb0080","doi-asserted-by":"crossref","first-page":"739","DOI":"10.18632\/oncotarget.344","article-title":"Systemic use of tumor necrosis factor alpha as an anticancer agent","volume":"2","author":"Roberts","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2024.167122_bb0085","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1002\/cncr.30845","article-title":"Efficacy and safety of recombinant human lymphotoxin-alpha derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: a randomized, multicenter, open-label, controlled, phase 2b trial","volume":"123","author":"Wang","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.bbadis.2024.167122_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1074-7613(00)80455-0","article-title":"LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator","volume":"8","author":"Mauri","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2024.167122_bb0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fcell.2020.00401","article-title":"Selective targeting of TNF receptors as a novel therapeutic approach","volume":"8","author":"Fischer","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","article-title":"Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes","volume":"114","author":"Micheau","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2024.167122_bb0105","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41584-021-00639-6","article-title":"Insights into the biology and therapeutic implications of TNF and regulatory T cells","volume":"17","author":"Salomon","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0110","doi-asserted-by":"crossref","first-page":"eaal2328","DOI":"10.1126\/scisignal.aal2328","article-title":"Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer","volume":"10","author":"Chen","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbadis.2024.167122_bb0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/377348a0","article-title":"Induction of apoptosis in mature T cells by tumour necrosis factor","volume":"377","author":"Zheng","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2024.167122_bb0125","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cyto.2012.11.005","article-title":"Mutants of lymphotoxin-\u03b1 with augmented cytotoxic activity via TNFR1 for use in cancer therapy","volume":"61","author":"Morishige","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.bbadis.2024.167122_bb0130","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/protein\/4.7.785","article-title":"Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin)","volume":"4","author":"Goh","year":"1991","journal-title":"Protein Eng."},{"key":"10.1016\/j.bbadis.2024.167122_bb0135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(93)90132-A","article-title":"Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation","volume":"73","author":"Banner","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2024.167122_bb0140","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41568-018-0009-4","article-title":"Oncolytic viruses as engineering platforms for combination immunotherapy","volume":"18","author":"Twumasi-Boateng","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2024.167122_bb0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0150","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.abk3436","article-title":"Oncolytic virotherapy as immunotherapy","volume":"374","author":"Melcher","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2024.167122_bb0155","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1158\/0008-5472.CAN-17-0468","article-title":"Oncolytic adenovirus and tumor-targeting immune modulatory therapy improve autologous Cancer vaccination","volume":"77","author":"Jiang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167122_bb0160","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0021-9258(18)45849-8","article-title":"The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-a resolution","volume":"267","author":"Eck","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2024.167122_bb0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jmr.300030207","article-title":"27 amino acid residues can be deleted from the N-terminus of human lymphotoxin without impairment of its cytotoxic activity","volume":"3","author":"Nishikawa","year":"1990","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bbadis.2024.167122_bb0170","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nbt812","article-title":"Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity","volume":"21","author":"Yamamoto","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0175","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.biomaterials.2009.10.015","article-title":"Creation of lysine-deficient mutant lymphotoxin-alpha with receptor selectivity by using a phage display system","volume":"31","author":"Yoshioka","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbadis.2024.167122_bb0180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09629350123139","article-title":"Establishment of a consistent L929 bioassay system for TNF-alpha quantitation to evaluate the effect of lipopolysaccharide, phytomitogens and cytodifferentiation agents on cytotoxicity of TNF-alpha secreted by adherent human mononuclear cells","volume":"10","author":"Shiau","year":"2001","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbadis.2024.167122_bb0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbadis.2024.167122_bb0190","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.cgt.7700543","article-title":"Generation of an adenoviral vector containing an addition of a heterologous ligand to the serotype 3 fiber knob","volume":"10","author":"Uil","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbadis.2024.167122_bb0195","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0200","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2024.167122_bb0205","first-page":"275","article-title":"Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells","volume":"8","author":"Kanerva","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167122_bb0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo","volume":"19","author":"Fueyo","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2024.167122_bb0215","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","article-title":"A protocol for rapid generation of recombinant adenoviruses using the AdEasy system","volume":"2","author":"Luo","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbadis.2024.167122_bb0220","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ab.2008.05.014","article-title":"Determining the concentration and the absorptivity factor at 260 nm in sodium dodecyl sulfate of the adenovirus reference material using analytical ultracentrifugation","volume":"380","author":"Berkowitz","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbadis.2024.167122_bb0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molstruc.2014.03.009","article-title":"MicroScale thermophoresis: interaction analysis and beyond","volume":"1077","author":"Jerabek-Willemsen","year":"2014","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbadis.2024.167122_bb0230","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1073\/pnas.87.8.3127","article-title":"Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies","volume":"87","author":"Brockhaus","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2024.167122_bb0235","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2024.167122_bb0240","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbrc.2011.12.016","article-title":"Copy number of adenoviral vector genome transduced into target cells can be measured using quantitative PCR: application to vector titration","volume":"417","author":"Pei","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2024.167122_bb0245","first-page":"651","article-title":"Protein engineering of tumor necrosis factor-beta and its applications in cancer, septicaemia and cachexia","volume":"22","author":"Goh","year":"1993","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.bbadis.2024.167122_bb0250","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0968-0004(01)01995-8","article-title":"The molecular architecture of the TNF superfamily","volume":"27","author":"Bodmer","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2024.167122_bb0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6807-12-8","article-title":"Are different stoichiometries feasible for complexes between lymphotoxin-alpha and tumor necrosis factor receptor 1?","volume":"12","author":"Mascarenhas","year":"2012","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0260","doi-asserted-by":"crossref","first-page":"ra83","DOI":"10.1126\/scisignal.2000954","article-title":"Solution of the structure of the TNF-TNFR2 complex","volume":"3","author":"Mukai","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbadis.2024.167122_bb0265","series-title":"Protein Modifications in Pathogenic Dysregulation of Signaling","first-page":"127","article-title":"Structural basis for signal initiation by TNF and TNFR","author":"Nakamura","year":"2015"},{"key":"10.1016\/j.bbadis.2024.167122_bb0270","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1016\/j.biomaterials.2011.04.018","article-title":"Fine tuning of receptor-selectivity for tumor necrosis factor-alpha using a phage display system with one-step competitive panning","volume":"32","author":"Abe","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbadis.2024.167122_bb0275","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1111\/febs.12419","article-title":"Lymphotoxin alpha induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor","volume":"280","author":"Etemadi","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2024.167122_bb0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41540-018-0058-z","article-title":"Model-based identification of TNFalpha-induced IKKbeta-mediated and IkappaBalpha-mediated regulation of NFkappaB signal transduction as a tool to quantify the impact of drug-induced liver injury compounds","volume":"4","author":"Oppelt","year":"2018","journal-title":"NPJ Syst Biol Appl"},{"key":"10.1016\/j.bbadis.2024.167122_bb0285","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2024.167122_bb0290","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.omto.2021.12.013","article-title":"Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5\/35 and Ad5\/3 over Ad5-delta-24-RGD in primary glioma cultures","volume":"24","author":"Stepanenko","year":"2022","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.bbadis.2024.167122_bb0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-1759(84)90081-4","article-title":"Normal levels of lymphotoxin secretion by freshly isolated and refrigerated human peripheral blood lymphocytes","volume":"67","author":"Evans","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbadis.2024.167122_bb0300","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/335256a0","article-title":"Transfer of a functional human immune system to mice with severe combined immunodeficiency","volume":"335","author":"Mosier","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2024.167122_bb0305","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1372131","article-title":"Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice","volume":"255","author":"Lapidot","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2024.167122_bb0310","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s44222-023-00030-y","article-title":"Engineering cytokine therapeutics","volume":"1","author":"Deckers","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.bbadis.2024.167122_bb0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-022-00557-6","article-title":"Emerging principles of cytokine pharmacology and therapeutics","volume":"22","author":"Saxton","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2024.167122_bb0320","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-023-00746-x","article-title":"Strategies to therapeutically modulate cytokine action","volume":"22","author":"Leonard","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2024.167122_bb0325","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nri1151","article-title":"Lymphotoxin\/light, lymphoid microenvironments and autoimmune disease","volume":"3","author":"Gommerman","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0330","first-page":"175","article-title":"The ligands and receptors of the lymphotoxin system","volume":"198","author":"Ware","year":"1995","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0335","doi-asserted-by":"crossref","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2024.167122_bb0340","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cellsig.2010.02.011","article-title":"Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2","volume":"22","author":"Boschert","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2024.167122_bb0345","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cytogfr.2011.11.007","article-title":"Biology and signal transduction pathways of the Lymphotoxin-alphabeta\/LTbetaR system","volume":"22","author":"Remouchamps","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbadis.2024.167122_bb0350","article-title":"Antagonistic antibody targeting TNFR2 inhibits regulatory T cell function to promote anti-tumor activity","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0355","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.4049\/jimmunol.180.5.2747","article-title":"Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators","volume":"180","author":"van Mierlo","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0360","first-page":"627","article-title":"Plasma membrane microdomains regulate TACE-dependent TNFR1 shedding in human endothelial cells","volume":"16","author":"D\u2019Alessio","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2024.167122_bb0365","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41584-021-00669-0","article-title":"Anti-inflammatory TNF receptor 2 signalling unravelled","volume":"17","author":"Clarke","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0370","doi-asserted-by":"crossref","first-page":"8781","DOI":"10.1073\/pnas.87.22.8781","article-title":"Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients","volume":"87","author":"Gatanaga","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2024.167122_bb0375","first-page":"225","article-title":"Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients","volume":"9","author":"Gatanaga","year":"1990","journal-title":"Lymphokine Res."},{"key":"10.1016\/j.bbadis.2024.167122_bb0380","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-019-0029-0","article-title":"Optimizing oncolytic virotherapy in cancer treatment","volume":"18","author":"Harrington","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2024.167122_bb0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.omto.2021.05.009","article-title":"Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation","volume":"22","author":"Farrera-Sal","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.bbadis.2024.167122_bb0390","first-page":"915","article-title":"Adenovirus improves the efficacy of adoptive T-cell therapy by recruiting immune cells to and promoting their activity at the tumor, Cancer","volume":"3","author":"Tahtinen","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bbadis.2024.167122_bb0395","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/cancers12051295","article-title":"Adenovirus and immunotherapy: advancing Cancer treatment by combination","volume":"12","author":"Sato-Dahlman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2024.167122_bb0400","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/cells10050978","article-title":"Systemic delivery of oncolytic adenovirus to tumors using tumor-infiltrating lymphocytes as carriers","volume":"10","author":"Santos","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2024.167122_bb0405","article-title":"Oncolytic adenovirus: prospects for Cancer immunotherapy","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0410","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrclinonc.2018.34","article-title":"CNS cancer: oncolytic adenovirus effective in patients with glioblastoma","volume":"15","author":"Sidaway","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0415","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1158\/1078-0432.CCR-20-1565","article-title":"Evolving status of clinical immunotherapy with oncolytic adenovirus","volume":"27","author":"Farrera-Sal","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167122_bb0420","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy","volume":"6","author":"Heise","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2024.167122_bb0425","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","article-title":"Humanized mouse models for immuno-oncology research","volume":"20","author":"Chuprin","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2024.167122_bb0430","doi-asserted-by":"crossref","first-page":"eaax7992","DOI":"10.1126\/scitranslmed.aax7992","article-title":"Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade","volume":"12","author":"Nakao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2024.167122_bb0435","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1038\/s41598-022-07153-z","article-title":"Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment","volume":"12","author":"Jin","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2024.167122_bb0440","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.183.4.1461","article-title":"Chronic inflammation caused by lymphotoxin is lymphoid neogenesis","volume":"183","author":"Kratz","year":"1996","journal-title":"J. Exp. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392400111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392400111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:19:49Z","timestamp":1748866789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392400111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S092544392400111X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167122","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An engineered TNFR1-selective human lymphotoxin-alpha mutant delivered by an oncolytic adenovirus for tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167122"}}